
Mahamaya Lifesciences IPO listed at a 1.75% premium on BSE at ₹116
Mahamaya Lifesciences IPO is listed with a premium of 1.75% at ₹116 on the NSE (Bombay Stock Exchange).

Mahamaya Lifesciences IPO is listed with a premium of 1.75% at ₹116 on the NSE (Bombay Stock Exchange).

Check out Workmates IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as

Check out Emmvee Photovoltaic IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates

Check out PhysicsWallah IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as

Check out Mahamaya Lifesciences IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates

The Tenneco Clean Air IPO allotment status is now available on the allotment date on November 17, 2025,

Fujiyama Power Systems’ subscription started on November 13, 2025, and the IPO will close on November 17, 2025,

Capillary Technologies IPO subscription started on Friday, November 14, 2025, and will close on November 18, 2025, as

Fujiyama Power Systems IPO subscription status started on ThursdayNovember 13, 2025 and will close on

Indian Emulsifiers Rights issue date is fixed, the rights issue is to open on October 24, 2025 and

Darshan Orna Rights issue date is fixed, the rights issue is to open on November 13, 2025 and

Titan Intech Rights issue date is fixed, the rights issue is to open on November 10, 2025 and